Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $22.11 in the prior trading day, Tyra Biosciences Inc (NASDAQ: TYRA) closed at $21.5, down -2.76%. In other words, the price has decreased by -$2.76 from its previous closing price. On the day, 0.63 million shares were traded. TYRA stock price reached its highest trading level at $22.74 during the session, while it also had its lowest trading level at $21.43.
Ratios:
Our goal is to gain a better understanding of TYRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.71 and its Current Ratio is at 17.71. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Raymond James on September 03, 2025, initiated with a Strong Buy rating and assigned the stock a target price of $35.
On January 07, 2025, UBS started tracking the stock assigning a Buy rating and target price of $28.UBS initiated its Buy rating on January 07, 2025, with a $28 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’25 when MORE ROBERT J sold 246,871 shares for $20.25 per share. The transaction valued at 5,000,026 led to the insider holds 3,833,425 shares of the business.
Alta Partners NextGen Fund II, bought 256,871 shares of TYRA for $5,394,291 on Nov 21 ’25. On Nov 18 ’25, another insider, Bensen Daniel, who serves as the Chief Operating Officer of the company, sold 75,633 shares for $16.07 each. As a result, the insider received 1,215,627 and left with 220,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TYRA now has a Market Capitalization of 1147500032 and an Enterprise Value of 878495104.
Stock Price History:
The Beta on a monthly basis for TYRA is 1.09, which has changed by 0.34375 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, TYRA has reached a high of $22.83, while it has fallen to a 52-week low of $6.42. The 50-Day Moving Average of the stock is 33.31%, while the 200-Day Moving Average is calculated to be 80.50%.
Shares Statistics:
The stock has traded on average 309.52K shares per day over the past 3-months and 630030 shares per day over the last 10 days, according to various share statistics. A total of 53.32M shares are outstanding, with a floating share count of 36.40M. Insiders hold about 31.73% of the company’s shares, while institutions hold 75.19% stake in the company. Shares short for TYRA as of 1763078400 were 4375041 with a Short Ratio of 14.13, compared to 1760486400 on 5782614. Therefore, it implies a Short% of Shares Outstanding of 4375041 and a Short% of Float of 12.0.
Earnings Estimates
. The current rating of Tyra Biosciences Inc (TYRA) reflects the combined expertise of 6.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.57, with high estimates of -$0.52 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.94 and -$2.07 for the fiscal current year, implying an average EPS of -$1.99. EPS for the following year is -$2.27, with 6.0 analysts recommending between -$1.85 and -$2.69.
